The importance of potassium and lactate for maximal exercise performance during beta blockade

References

• Anderson R L, Wilmore J H, Joyner M J, et al. Effects of cardioselective and nonselective beta-adrenergic blockade on the performance of highly trained runners. Am J Cardiol 1985; 55: 149D–54D
   PubMed Web of Science ®Google Scholar
• Epstein S E, Robinson B F, Kahler R L, Braunvald E. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest 1965; 44: 1745–53
   PubMed Web of Science ®Google Scholar
• Galbo H, Hoist J J, Christensen N J, Hilsted J. Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J Appl Physiol 1976; 40(6)855–63
   PubMed Web of Science ®Google Scholar
• Gullestad L, Dolva L Ø, Søyland E, Kjekshus J. Difference between beta-1-selective and nonselective betablockade during continuous and intermittent exercise. Clinical Physiology 1988; 8: 487–99
   Google Scholar
• Kaiser L, Kaiser P, Karlsson J, Rossner S. Beta-blockers and running. Am Heart J 1980; 100: 943–4
   Google Scholar
• Lundborg P, Åstrøm H, Bengtsson C, Fellenius E, Von Schenk H, Svensson L, Smith U. Effect of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci 1981; 61: 299–305
   PubMed Web of Science ®Google Scholar
• Pearson S B, Banks D C, Patrick J M. The effects of beta-adrenceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol 1979; 8: 143–8
   PubMed Web of Science ®Google Scholar
• Sklar J, Johnston G D, Overlie P, et al. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Circulation 1982; 65: 894–9
   PubMed Web of Science ®Google Scholar
• Wilmore J H, Ewy G A, Morton A R, et al. The effect of beta-adrenergic blockade on submaximal and maximal exercise performance. J Cardiac Rehab 1983; 3: 30–6
   Google Scholar
• Wilmore J H, Freund B J, Joyner M J, et al. The acute response to submaximal and maximal exercise consequent to beta adrenergic blockade: implication for the prescription of exercise. Am J Cardiol 1985; 55: 135D–41D
   PubMed Web of Science ®Google Scholar
• Frisk-Holmberg M, Jorfeldt L, Juhlin-Danfeldt A, Karlsson J. Metabolic changes in muscle on long-term alprenolol therapy. Clin Pharmacol Ther 1979; 26: 566–71
   PubMedGoogle Scholar
• McSorley P D, Warren D J. Effects of propranolol and metoprolol on the peripheral circulation. Br Med J 1978; 2: 1598–1600
   PubMed Web of Science ®Google Scholar
• Brammel H L, Gal J, Nies A S. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Circulation 1982; 65: 894–9
   Google Scholar
• Lund-Johansen P. Haemodynamic long-term effects of timolol at rest and during exercise in essential hypertension. Acta Med Scand 1976; 199: 263–7
   PubMed Web of Science ®Google Scholar
• Brown M J, Brown D C, Murphy M B. Hypokalemia from beta-2-receptor stimulation by circulating epinephrine. New Engl J Med 1983; 309: 1414–9
   PubMed Web of Science ®Google Scholar
• Carlsson E, Fellenius E, Lundborg P, Svensson L. Beta-adrenoceptor blockers, plasma potassium and exercise. Lancet 1978; ii: 424–5
   Google Scholar
• McDonald I A, Benett T, Brown A M, Wilcox R G, Skene A M. The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged exercise in hypertensive man. Br J Clin Pharmacol 1984; 17: 283–93
   Google Scholar
• Epstein F H. Signs and symptoms of electrolyte disorders. Clinical disorders of fluid and electrolyte metabolism, M H Maxwell, C R Kleeman. McGraw-Hill, New York 1980; 499–530
   Google Scholar
• Jones D A. Muscle fatigue due to changes beyond the neuromuscular junction. Human muscle fatigue: physiological mechanisms, R Porter, J Whelan. Pitman Medical, London 1981; 178–96
   Google Scholar
• Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehab Med 1970; 2–3: 92–8
   Google Scholar
• Larsen S, Osnes M. The unstimulated duodenal pressure activity in healthy subjects. Scand J Gastroenterol 1987; 22(Suppl. 131)1–33
   PubMed Web of Science ®Google Scholar
• Kendal M, Stuart A. The advanced theory of statistics. Charles Griffin, London 1977
   Google Scholar
• Bowman W C. Effect of adrenergic activators and inhibitors or the skeletal muscles. Adrenergic activators and inhibitors, L Szekeres. Springer-Verlag, Berlin 1980
   Google Scholar
• Ellis M E, Sahay J N, Chatterjee S S, Cruickshank F M, Ellis S H. Cardioselectivity of atenolol in astmatic patients. Eur J Clin Pharmacol 1981; 21: 173–6
   PubMedGoogle Scholar
• Hermansen L. Effect of acidosis on skeletal muscle performance during maximal exercise in man. Bull Europ Physiopathy Resp 1979; 15: 229–38
   PubMedGoogle Scholar
• Juhlin-Danfeldt A. Beta-adrenoceptor blockade and exercise: Effects on endurance and physical training. Acta Med Scand 1983; 62: 49–54
   Google Scholar
• Kaiser P. Physical performance and muscle metabolism during beta-adrenergic blockade in man. Acta Physiol Scand 1984, Suppl. 536: 1–53
   Google Scholar
• Hirche H, Schumacher E, Hagemann H. Extracellular K balance of the gastrocnemius muscle of the dog during exercise. Phlugers Arch 1980; 387: 231–7
   PubMed Web of Science ®Google Scholar
• Hermansen L, Orheim A, Seiersted O M. Metabolic acidosis and changes in water and electrolyte balance in relation to fatigue during maximal exercise of short duration. Int J Sport Med 1984; 5: 110–5
   Google Scholar
• Pollen R H, Williams R H. Hypercalemic neuro-myopathy in Addison's disease. New Engl J Med 1960; 263: 273–8
   PubMed Web of Science ®Google Scholar
• Wang P, Clausen T. Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet 1976; i: 221–3
   Google Scholar
• Epstein F H, Rosa R M. Adrenergic control of serum potassium. New Engl J Med 1983; 309: 1450–1
   PubMed Web of Science ®Google Scholar
• Clausen T, Flatman J A. Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle. Br J Pharmacol 1980; 68: 749–55
   PubMed Web of Science ®Google Scholar
• Williams M E, Rosa R M, Silva P, Brown R S, Epstein F H. Impairment of extrarenal potassium disposal by alpha adrenergic stimulation. New Engl J Med 1984; 311: 145–9
   Google Scholar
• Irving M H, Britton B J, Wood W G, Padgham C, Carruthers M. Effects of beta adrenergic blockade on plasma catecholamines in exercise. Nature 1974; 248: 531–3
   Google Scholar
• Buhler F R, Bolli P, Hulthen L, Ammann F W. Beta- und alpha- adrenozeptorblocker im anti-hypertensiven therapieplan: Empfelungen fur die praxis. Ther Umschau 1981; 38: 17–23
   Google Scholar
• Stiles G L, Taylor S, Lefkowitz R J. Human cardiac beta-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand banding. Life Sci 1983; 33: 467–73
   PubMed Web of Science ®Google Scholar